Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward William Gallagher, University College Dublin, speaking at Diagnostics & Biomarkers 2015.
Comprehensive Integration, Automation and Parallelisation of Multi-step Bioanalytical Assay Formats on the Centrifugal Microfluidic Lab-on-a-Disc Platform Jens Ducree, Biomedical Diagnostics Institute/Dublin City University, speaking at Lab-on-a-Chip & Microfluidics 2015
Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit Kevin Cox, Imanova Limited, speaking at Diagnostics & Biomarkers.
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM) Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
The Application of a Resonant Coil Magnetometer for Point of Care Diagnostic Applications Richard Luxton, University of the West of England, speaking at Point of Care Diagnostics 2015
Discovery of Potent and Selective Inhibitors of Monopolar Spindle 1 (MPS1) Kinase Rob van Montfort, The Institute of Cancer Research, speaking at Discovery Chemistry Congress 2015.
Mass spectrometry based metabolomics in chemical and nanomaterial risk assessment In this webinar, Mark Viant, Professor of Metabolomics at the University of Birmingham, will introduce the concepts of metabolomics as well as the challenges faced in chemical hazard assessment.
A Structured Approach to Academic Drug Discovery Simon Ward, University of Sussex, speaking at Discovery Chemistry Congress 2015
Exploring Protein-protein Interactions Using Scaffolded and Assembled Peptides as Synthetic Binding Site Mimics Jutta Eichler, University of Erlangen-Nuremberg, speaking at Discovery Chemistry Congress 2015.
Bioorthogonal Palladium-Labile Prodrugs for Site-Specific Anticancer Therapy Asier Unciti-Broceta, University of Edinburgh, speaking at Discovery Chemistry Congress 2015.